Latest News

  • Quest Diagnostics, Walmart Partner To Offer Lab Testing Services In Stores

    Modern Healthcare | Walmart Stores and Quest Diagnostics announced a partnership Monday that will bring Quest's laboratory testing services to 15 Walmart locations in Florida and Texas by the end of the year.

    Jun 27, 2017
  • Reimbursement Of Companion Diagnostics: Discussions For Precision Medicine

    Diagnostics World Brief | Omar Perez of Pfizer is featured on this podcast from Cambridge Health Tech Institute for the Next Generation Diagnostic Summit. Topics include using key commercialization challenges for precision medicine or companion diagnostics, starting the discussion between a diagnostic and a pharmaceutical company regarding co-commercialization, and more.

    Jun 27, 2017
  • Emulate Awarded Grant To Fund Use Of Human Emulation System Aboard The International Space Station

    Diagnostics World Brief | Emulate announced that it has received a research grant to use the company’s human Brain-Chip system and develop a fully automated research platform, to conduct experiments on the International Space Station.

    Jun 22, 2017
  • Geisinger’s Strategy For Clinical NGS Implementation

    Diagnostics World Brief | Marc Williams of Geisinger Health System is featured on this podcast from Cambridge Health Tech Institute for the Next Generation Diagnostic Summit. Topics include implementation of NGS in routine car, challenges to overcome, and exciting applications of NGS.

    Jun 20, 2017
  • A Look Ahead To The Next Generation Dx Summit

    Diagnostics World | The Next Generation Dx Summit will take place August 15-18 in Washington, D. C. Featuring 12 different conference programs covering an array of topics from cancer immunotherapy to point-of-care testing, here are a few highlights for #NGDx17.

    Jun 19, 2017
  • Cancer Immunotherapy's Past, Present, And Future

    Diagnostics World | Allan Haberman’s new report, Cancer Immunotherapy: Building on Initial Successes to Improve Clinical Outcomes, discusses the major theme of “second wave” immuno-oncology. He builds on a 2014 Insight Pharma Report which focused on the major classes of cancer immunotherapy drugs that were then emerging from academic and corporate research.

    Jun 16, 2017
  • A Multiplexed Approach For Predicting Responses To Cancer Immunotherapy

    Diagnostics World Brief | Robert Anders of Johns Hopkins Medicine is featured on this podcast from Cambridge Health Tech Institute for the Next Generation Diagnostic Summit, which runs August 15-18 in Washington, DC. Topics include the integration of genomic, proteomic and immunological markers for cancer immunotherapy, challenges in implementing multiplex approaches, and more.

    Jun 14, 2017
  • What Will It Take To Make NGS Standard Of Care?

    Diagnostics World Brief | The Faculty Investigator and Director at HudsonAlpha Institute for Biotechnology sits down to discuss her work in whole genome sequencing to diagnose and monitor rare diseases.

    Jun 9, 2017
  • FBI Raids Offices Of Lab That Pays Doctors To Promote Genetic Tests

    STAT | Proove Biosciences, an Irvine, Calif., firm that purports to determine a patient's likelihood of becoming addicted to opioids, was raided on Wednesday.

    Jun 8, 2017
  • Caris, NCI, And ECOG-ACRIN Collaborate To Molecularly Identify Candidates For The NCI-MATCH Clinical Trial

    Diagnostics World Brief | Caris Life Sciences announced a collaboration with the National Cancer Institute for the NCI-Molecular Analysis for Therapy Choice precision medicine trial, which is being implemented by the ECOG-ACRIN Cancer Research Group.

    Jun 7, 2017
  • Interpace Diagnostics Announces Agreement With Einstein Medical Center Of Philadelphia

    Diagnostics World Brief | Interpace announced that the company has entered into a Laboratory Services Agreement with Einstein Medical Center of Philadelphia (Einstein) to provide expanded laboratory analytical services to Einstein for improved identification of indeterminate thyroid nodules.

    Jun 6, 2017
  • Sema4 Eric Schadt’s Genomics Startup Spins Out of Sinai to Raise Cash

    Xconomy | Eric Schadt has been incubating a genomic data project within the Icahn School of Medicine at Mount Sinai for more than five years. Today, the company, Sema4, formally launches with 300+ employees.

    Jun 1, 2017